A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women
Clinical trial NCT01059435 · COMPLETED
Trial details
- NCT number
- NCT01059435
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-13
- Primary completion
- 2007-07-06
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.